Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population

Molecular Biology Reports

Volumn 40, Issue 1, 2013, Pages 463-468

  Liang, Shu ^a   Pan, Min ^a   Hu, Nan ^a   Wu, Yu Yu ^a   Chen, Hui ^a   Zhu, Jian Hua ^a   Guan, Huai Jin ^a   Sang, Ai Min ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Case control; Chinese; Diabetic retinopathy; Genetic polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ACE GENE; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE HAN; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84871260048     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2081-2     Document Type: Article

References (37)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844-851
2. Zhu Y, Zhang XL, Zhu BF, Ding YN (2012) Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats. Mol Biol Rep 39:3727-3735
3. Cilensek I, Mankoc S, Globocnik PM, Petrovic D (2012) The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus. Mol Biol Rep 39:7061-7067
4. Sjolie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L, Fuller J (1997) Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM complications study. Ophthalmology 104:252-260
5. The Diabetes Control and Complications Trial Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44:968-983
6. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412
7. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30years. Arch Ophthalmol 102:520-526
8. Jerneld B, Algvere P (1986) Relationship of duration and onset of diabetes to prevalence of diabetic retinopathy. Am J Ophthalmol 102:431-437
9. Sallam A, Scanlon PH, Stratton IM, Jones V, Martin CN, Brelen M, Johnston RL (2011) Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy. Diabet Med 28:741-746
10. Hallman DM, Huber JC Jr, Gonzalez VH, Klein BE, Klein R, Hanis CL (2005) Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 28:1163-1168
11. Hogeboom van Buggenum IM, Polak BC, Reichert-Thoen JW, de Vries-Knoppert WA, van Hinsbergh VW, Tangelder GJ (2002) Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. Diabetologia 45:203-209
12. Chaturvedi N, Sjolie AK, Stephenson JM et al (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID study group. EURODIAB controlled trial of lisinopril in insulin-dependent diabetes mellitus. Lancet 351:28-31
13. Nagi DK, Mansfield MW, Stickland MH, Grant PJ (1995) Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabet Med 12:997-1001
14. Feghhi M, Nikzamir A, Esteghamati A, Farahi F, Nakhjavani M, Rashidi A (2008) The relationship between angiotensin-converting enzyme insertion/deletion polymorphism and proliferative retinopathy in type 2 diabetes. Diabetes Res Clin Pract 81:e1-e4
15. Wiwanitkit V (2008) Angiotensin-converting enzyme gene polymorphism is correlated to diabetic retinopathy: a meta-analysis. J Diabetes Complicat 22:144-146
16. Matsumoto A, Iwashima Y, Abiko A, Morikawa A, Sekiguchi M, Eto M, Makino I (2000) Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy. Diabetes Res Clin Pract 50:195-202
17. Pan M, Jiang MH, Wei MF et al (2009) Association of angiotensin- converting enzyme gene 2350G>A polymorphism with myocardial infarction in a Chinese population. Clin Appl Thromb Hemost 15:435-442
18. Levy D, DeStefano AL, Larson MG et al (2000) Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension 36:477-483
19. Zhu X, Bouzekri N, Southam L et al (2001) Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 68:1139-1148
20. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
21. Danser AH, Derkx FH, Admiraal PJ, Deinum J, de Jong PT, Schalekamp MA (1994) Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 35:1008-1018
22. Wagner J, Jan DAH, Derkx FH et al (1996) Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 80:159-163
23. Yucel O, Karahan O, Zorlu A, Manduz S (2012) Familial genetic risk factors in premature cardiovascular disease: a family study. Mol Biol Rep 39:6141-6147
24. Sjolie AK, Chaturvedi N (2002) The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy. J Hum Hypertens 16(Suppl 3):S42-S46
25. Mehri S, Mahjoub S, Hammami S et al (2012) Renin-angiotensin system polymorphisms in relation to hypertension status and obesity in a Tunisian population. Mol Biol Rep 39:4059-4065
26. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346
27. Firouzabadi N, Tajik N, Shafiei M, Ebrahimi SA, Bakhshandeh H (2011) Interaction of A-240T and A2350G related genotypes of angiotensin-converting enzyme (ACE) is associated with decreased serum ACE activity and blood pressure in a healthy Iranian population. Eur J Pharmacol 668:241-247
28. Saeed M, Mekan SF, Rabbani MA, Arain FM, Arif M, Shaharyar S (2005) Angiotensin converting enzyme (ACE) gene polymorphisms and lupus disease severity: a promising link. Ann Rheum Dis 64:164-165
29. Vasudevan R, Ismail P, Stanslas J, Shamsudin N (2008) Association of G2350A polymorphism of angiotensin converting enzyme gene with essential hypertension. J Biol Sci 8:1045-1050
30. Kehoe PG, Katzov H, Feuk L et al (2003) Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 12:859-867
31. McKenzie CA, Abecasis GR, Keavney B et al (2001) Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 10:1077-1084
32. Bloem LJ, Manatunga AK, Pratt JH (1996) Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 27:62-66
33. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12:205-216
34. Liew G, Klein R, Wong TY (2009) The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin 49:35-52
35. Susser M, Susser E (1987) Indicators and designs in genetic epidemiology: separating heredity and environment. Rev Epidemiol Sante Publique 35:54-77
36. Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, Ye CJ (2009) Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol 220:538-547
37. Haffner SM, Mitchell BD, Moss SE et al (1993) Is there an ethnic difference in the effect of risk factors for diabetic retinopathy. Ann Epidemiol 3:2-8